Imagerie et bilan d’extension du cancer du testicule

  • Y. Eydan
Part of the Monographies en urologie book series (MONOGRAPHIES)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Houlgatte A, Mottet N, Ibora F et al. (2004) Prise en charge des métastases lymphonodales rétropéritonéales des tumeurs germinales du testicule. Prog Urol 13: 147–59Google Scholar
  2. 2.
    Donohue JP, Zaachary JM, Maynard BR (1982) Distribution of retropéritoneal lymph node metastases in non seminomatous testis cancer. J Urol 128: 315–20PubMedGoogle Scholar
  3. 3.
    Weissbach L, Boedefeld EA (1987) Localization of solitary and multiple metastases in stage II non seminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 138: 77–82PubMedGoogle Scholar
  4. 4.
    Fossa SD, Ous S, Stenwig AE et al. (1990) Distribution of peritoneal lymph node metastases in patients with non seminomatous tsticular cancer in clinical stage I. Eur Urol 17: 107–12PubMedGoogle Scholar
  5. 5.
    Leibovitch I, Foster RS, Kopecky KK et al. (1998) Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitative immunohistochemical, histopathologic, and radiologic assesment. J Clin Oncol 16: 261–8PubMedGoogle Scholar
  6. 6.
    Fernandez EB, Moul JW, Foley JP et al. (1994) Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I non seminomatous germ cell tumors. Urology 44: 448–52Google Scholar
  7. 7.
    Owens EJ, Kabala J, Goddard P (2004) Imaging of testicular tumours. Hosp Med 65: 18–21PubMedGoogle Scholar
  8. 8.
    Grubnic S, Vinnicombe SJ, Norman AR et al. (2001) MR evaluation of normal retroperitoneal and pelvic lymph nodes. Clin Radiol 57: 193–200Google Scholar
  9. 9.
    Bellin MF, Roy G, Kinkel K et al. (1998) Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles — initial clinical experience. Radiology 207: 799–808PubMedGoogle Scholar
  10. 10.
    Harisinghani MG, Saini S, Weissleder R et al. (1999) MR Lympangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignacies: radiographic-pathologic correlation. AJR 172: 1347–52PubMedGoogle Scholar
  11. 11.
    Albers P, Bender H, Yilmazz H et al. (1999) Positron emission tomography in the clinical staging of patients with stage I and II testicular germ cell tumors. Urology 53: 808–11PubMedCrossRefGoogle Scholar
  12. 12.
    Nathan PD, Rustin GR (2003) The role of CT scanning in the surveillance of testicular tumors. J Clin Oncol 15: 121–2Google Scholar
  13. 13.
    White PM, Adamson DJA, Howard GCW et al. (1999) Imaging of the thorax in the management of germ cell testiculars tumours. Clin Radiol 54: 207–11PubMedCrossRefGoogle Scholar
  14. 14.
    Harvey ML, Geldart TR, Duell R et al. (2002) Routine computerized tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ cell cancer — a necessary risk? Ann Oncol 13: 237–42PubMedCrossRefGoogle Scholar
  15. 15.
    Baniel J, Foster RS, Rowland RG et al. (1995) Complications of post chimiotherapy retroperitoneal lymph node dissection. J Urol 153: 976–80PubMedGoogle Scholar
  16. 16.
    Donohue JP, Thornhill JA, Foster RD et al. (1991) Resection of the inferior vena cava during RPLND for metastatic germ cell cancer: indications and results. J Urol 146: 346–9PubMedGoogle Scholar
  17. 17.
    NG CS, Husband JE, Padhani AT et al. (1997) Evaluation by magnetic resonance imaging of the inferior vena cava in patients with non seminomatous germ cell tumors of the testis metastatic to the retroperitoneum. Br J Urol 79: 942–51PubMedGoogle Scholar
  18. 18.
    Corral DA, Varma DG, Jackson EF et al. (2000) Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection. Urology 55: 262–6PubMedCrossRefGoogle Scholar
  19. 19.
    Donohue JP, Rowland RG, Kopecky K et al. (1987) Correlation of computerized tomographic changes and histological finding in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol 137: 1176–9PubMedGoogle Scholar
  20. 20.
    Putra LJ, Lawrentschuk N, Ballok Z, et al. (2004) 18F-Fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chimiotherapy. Urology 64: 1202–7PubMedCrossRefGoogle Scholar
  21. 21.
    De Santis M, Becherer A, Bokermeyer C et al. (2004) 2-18fluoro-deoxy-D-glucose Positron Emission Tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22: 1034–9PubMedGoogle Scholar
  22. 22.
    Herr HW, Sheinfeld J, Puc HS et al. (1997) Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157: 860–2PubMedGoogle Scholar
  23. 23.
    Livsey JE, Taylor B, Mobareck N et al. (2001) Patterns of relapse following radiotherapy for stage I seminoma of the testis: implications for followup. Clin Oncol 13: 296–300.Google Scholar

Copyright information

© Springer-Verlag France, Paris 2006

Authors and Affiliations

  • Y. Eydan
    • 1
  1. 1.Clinique MutualisteSaint-Étienne Cedex 2

Personalised recommendations